CO5150177A1 - Derivados de hidrazina - Google Patents

Derivados de hidrazina

Info

Publication number
CO5150177A1
CO5150177A1 CO99074402A CO99074402A CO5150177A1 CO 5150177 A1 CO5150177 A1 CO 5150177A1 CO 99074402 A CO99074402 A CO 99074402A CO 99074402 A CO99074402 A CO 99074402A CO 5150177 A1 CO5150177 A1 CO 5150177A1
Authority
CO
Colombia
Prior art keywords
lower alkyl
aryl
cycloalkyl
alkyl
heterocyclyl
Prior art date
Application number
CO99074402A
Other languages
English (en)
Inventor
Michael John Broadhurst
William Henry Johnson
Daryl Simon Walter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO5150177A1 publication Critical patent/CO5150177A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/48—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
    • C07C311/49—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compuestos de la fórmula general<EMI FILE="99074402_1" ID="1" IMF=JPEG >en dondeR1 representa alquilo inferior, alquenilo inferior, cicloalquilo inferior, cicloalquilo inferior-alquilo inferior, arilo o aril-alquilo inferior; R2 representa heterociclilo o NR5R6; R3 representa hidrógeno, alquilo inferior, halo-alquilo inferior, ciano-alquilo inferior, hidroxi-alquilo inferior, amino-alquilo inferior, alcoxilo inferior-alquilo inferior, alcoxicarbonilo inferior-alquilo inferior, cicloalquilo inferior-alquilo inferior, aril-alquilo inferior, heterociclililo-alquilo inferior, heterociclilcarbonil-alquilo inferior, alquenilo inferior, alquinilo inferior, cicloalquilo inferior, arilo, heteroarilo o aril-alquilo inferior;R4 representa alquilo inferior, alquenilo inferior, cicloalquilo inferior, cicloalquilo inferior-alquilo inferior o una agrupación de la fórmula -Z-arilo, -Z-heterociclilo o - (CH2)n-CH=CR7R8; R5 y R6 representan cada uno, independientemente, hidrógeno o alquilo inferior; y R7 y R8 representan cada uno, independientemente hidrógeno o alquilo inferior o R7 y R8 juntos representan alquileno inferior en donde un grupo CH2 está opcionalmente sustituido por un hetero átomo; X y Z representan cada uno un grupo espaciador; y n significa 0, 1 ó 2; y sus sales farmacéuticamente aceptables.
CO99074402A 1998-11-27 1999-11-25 Derivados de hidrazina CO5150177A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9826153.0A GB9826153D0 (en) 1998-11-27 1998-11-27 Hydrazine derivatives

Publications (1)

Publication Number Publication Date
CO5150177A1 true CO5150177A1 (es) 2002-04-29

Family

ID=10843268

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99074402A CO5150177A1 (es) 1998-11-27 1999-11-25 Derivados de hidrazina

Country Status (21)

Country Link
US (1) US6265446B1 (es)
EP (1) EP1133471B1 (es)
JP (1) JP3683180B2 (es)
KR (1) KR100449793B1 (es)
CN (1) CN1209352C (es)
AR (1) AR024521A1 (es)
AT (1) ATE250025T1 (es)
AU (1) AU760497B2 (es)
BR (1) BR9915752A (es)
CA (1) CA2351321A1 (es)
CO (1) CO5150177A1 (es)
DE (1) DE69911455T2 (es)
DK (1) DK1133471T3 (es)
ES (1) ES2205913T3 (es)
GB (1) GB9826153D0 (es)
PE (1) PE20001300A1 (es)
PT (1) PT1133471E (es)
TR (1) TR200101495T2 (es)
UY (1) UY25820A1 (es)
WO (1) WO2000032570A1 (es)
ZA (1) ZA200104276B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE494261T1 (de) * 1999-10-27 2011-01-15 Univ Rice William M Makroskopische geordnete anordnung von kohlenstoffnanoröhren
WO2005021489A2 (en) 2002-12-23 2005-03-10 Wyeth Holdings Corporation Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2058797A1 (en) 1991-02-01 1992-08-02 Michael John Broadhurst Amino acid derivatives
US5399589A (en) 1992-12-17 1995-03-21 Basf Aktiengesellschaft Oxalyl hydrazide-hydroxamic acid derivatives, their preparation and their use as fungicides
GB9607119D0 (en) * 1996-04-04 1996-06-12 Chiroscience Ltd Compounds
CZ298048B6 (cs) * 1996-09-10 2007-06-06 British Biotech Pharmaceuticals Limited Farmaceutický prostredek a deriváty kyseliny hydroxamové
US6235787B1 (en) * 1997-06-30 2001-05-22 Hoffmann-La Roche Inc. Hydrazine derivatives
AU2298399A (en) 1998-02-06 1999-08-23 Yoshitomi Pharmaceutical Industries, Ltd. Novel azapeptide type hydroxamic acid derivatives
US6239151B1 (en) 1998-06-26 2001-05-29 Hoffmann-La Roche Inc. Compounds as inhibitor of tumor necrosis factor alpha release

Also Published As

Publication number Publication date
JP3683180B2 (ja) 2005-08-17
TR200101495T2 (tr) 2001-10-22
ATE250025T1 (de) 2003-10-15
ES2205913T3 (es) 2004-05-01
US6265446B1 (en) 2001-07-24
AR024521A1 (es) 2002-10-16
AU1652400A (en) 2000-06-19
EP1133471A1 (en) 2001-09-19
JP2002531438A (ja) 2002-09-24
AU760497B2 (en) 2003-05-15
DE69911455T2 (de) 2004-07-08
DK1133471T3 (da) 2004-01-26
PT1133471E (pt) 2004-02-27
BR9915752A (pt) 2001-08-28
CA2351321A1 (en) 2000-06-08
KR100449793B1 (ko) 2004-09-22
CN1328545A (zh) 2001-12-26
UY25820A1 (es) 2001-07-31
WO2000032570A1 (en) 2000-06-08
ZA200104276B (en) 2002-08-26
KR20010080553A (ko) 2001-08-22
DE69911455D1 (de) 2003-10-23
PE20001300A1 (es) 2000-12-01
CN1209352C (zh) 2005-07-06
EP1133471B1 (en) 2003-09-17
GB9826153D0 (en) 1999-01-20

Similar Documents

Publication Publication Date Title
CO5251410A1 (es) Derivados de nitrilo como inhibidores de la captesina k
ATE204269T1 (de) Substituierte biphenyl- oder phenylpyridinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
TNSN01011A1 (en) 3-AMINOQUINAZOLIN-2,4-DIONE ANTIBACTERIAL AGENTS
TR200402300T4 (tr) İmidazopirimidin türevleri ve triazolopirimidin türevleri.
ATE287096T1 (de) Elektrochrome vorrichtung
CO5031253A1 (es) Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen
PE20050354A1 (es) Aminas ciclicas de bace-1 que poseen un sustituyente heterociclico
AR240929A2 (es) &#34;n-piridinsulfonil-n&#39;-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas&#34;
ATE288895T1 (de) Wachstumshormon-freisetzende oxindolderivate
TR200201205T2 (tr) N-ikame edilmiş karbamoiloksialkil-azolyum türevleri.
ES2194486T3 (es) Derivados de diacilhidrazina como inhibidores de integrina.
CO5251427A1 (es) Oxazolidinonas que tienen la fucion de sulfoximina
CO5080791A1 (es) Derivados de la piperidina que tienen efectos sobre sistemas con serotonina
CO5261565A1 (es) Inhibidores de n-(5-(((5-alquil-2-oxazolil)metil)tio)-2-tiazolil)-carboxamida de cinasas dependientes de ciclina
DE60318826D1 (de) Alkoxypyridinderivate
PA8478301A1 (es) Derivados ftalacinicos inhibidores de la fosfodiesterasa 4
CO5640079A2 (es) Nuevos bioisosteros de actinonina
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
CO5150177A1 (es) Derivados de hidrazina
CO5180536A1 (es) Inhibidores de proteasas catepsina
CO4970700A1 (es) Proceso para la preparacion de pirimidinas sustituidas
DK422688D0 (da) Substituerede pyridylethanolaminer og fysiologisk acceptable salte og n-oxider deraf, deres fremstilling og anvendelse samt mellemprodukter og disses fremstilling
TW330147B (en) Halogenobenzimidazoles, their preparation processes and their use
ATE119523T1 (de) Isochinolinderivate und ihre salze als proteasehemmer.
CO5150174A1 (es) Bi-pirrolidinilvinil (carba) cefalosporinas